Molecular Partners Ag (MOLN) EBT Margin Growth (1y) (2021 - 2026)
Molecular Partners Ag (MOLN) EBT Margin Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.90 Bn | 131.05 Bn | 2.84 Bn | -153.00 |
| 2 | Regeneron Pharmaceuticals | 86.10 Bn | 78.11 Bn | 3.93 Bn | -571.00 |
| 3 | Argenx Se | 65.56 Bn | 60.37 Bn | 1.37 Bn | 546.00 |
| 4 | Moderna | 55.82 Bn | 50.68 Bn | 52.00 Mn | 4,709.00 |
| 5 | BeOne Medicines | 42.14 Bn | 37.04 Bn | 1.53 Bn | 1,076.00 |
| 6 | Alnylam Pharmaceuticals | 31.67 Bn | 28.36 Bn | 992.69 Mn | 1,911.00 |
| 7 | BioNTech SE | 27.74 Bn | 9.35 Bn | 668.28 Mn | -2,507.00 |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn | 29,565.00 |
| 9 | Royalty Pharma | 27.38 Bn | 26.54 Bn | - | -392.00 |
| 10 | Molecular Partners Ag | 163.99 Mn | 163.99 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 613.00 |
| Dec 31, 2025 | -95.36 Mn |
| Sep 30, 2025 | -9,826.00 |
| Jun 30, 2025 | 97.23 Mn |
| Mar 31, 2025 | 30,972.00 |
| Dec 31, 2024 | 109.85 Mn |
| Sep 30, 2024 | 45,017.00 |
| Jun 30, 2024 | -96.86 Mn |
| Mar 31, 2024 | -41,362.00 |
| Dec 31, 2023 | -99,130.00 |
| Sep 30, 2023 | -45,018.00 |
| Jun 30, 2023 | -381,383.00 |
| Mar 31, 2023 | 0.00 |
| Dec 31, 2022 | 8,132.00 |
| Sep 30, 2022 | 34,840.00 |
| Jun 30, 2022 | -4,189.00 |
| Mar 31, 2022 | 0.00 |
| Dec 31, 2021 | -2.00 |
| Sep 30, 2021 | -34,841.00 |